ICON Other Share Holders Equity 2010-2024 | ICLR

ICON other share holders equity from 2010 to 2024. Other share holders equity can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • ICON other share holders equity for the quarter ending June 30, 2024 was $0.001B, a 0% increase year-over-year.
  • ICON other share holders equity for 2023 was $0.001B, a 0% decline from 2022.
  • ICON other share holders equity for 2022 was $0.001B, a 2.47% increase from 2021.
  • ICON other share holders equity for 2021 was $0.001B, a 0% decline from 2020.
ICON Annual Other Share Holders Equity
(Millions of US $)
2023 $1
2022 $1
2021 $1
2020 $1
2019 $1
2018 $1
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $-9
2011 $-16
2010 $0
2009 $13
ICON Quarterly Other Share Holders Equity
(Millions of US $)
2024-06-30 $1
2024-03-31 $1
2023-12-31 $1
2023-09-30 $1
2023-06-30 $1
2023-03-31 $1
2022-12-31 $1
2022-09-30 $1
2022-06-30 $1
2022-03-31 $1
2021-12-31 $1
2021-09-30 $1
2021-06-30 $1
2021-03-31 $1
2020-12-31 $1
2020-09-30 $1
2020-06-30 $1
2020-03-31 $1
2019-12-31 $1
2019-09-30 $1
2019-06-30 $1
2019-03-31
2018-12-31 $1
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30 $-50
2015-03-31 $-60
2014-12-31
2014-09-30 $-17
2014-06-30 $1
2014-03-31 $1
2013-12-31 $2
2013-09-30 $-7
2013-06-30 $-19
2013-03-31 $-22
2012-12-31 $-9
2012-09-30 $-13
2012-06-30 $-25
2012-03-31 $-7
2011-12-31 $-16
2011-09-30 $-1
2011-06-30 $14
2011-03-31 $12
2010-12-31 $0
2010-09-30 $3
2010-06-30 $-21
2010-03-31 $-4
2009-12-31 $13
2009-09-30 $18
2009-06-30 $11
2009-03-31 $-2
Sector Industry Market Cap Revenue
Medical Medical Services $24.951B $8.120B
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $125.093B 15.25
Cencora (COR) United States $45.021B 17.20
DiDi Global (DIDIY) China $18.956B 0.00
Avantor (AVTR) United States $18.396B 27.90
Natera (NTRA) United States $15.720B 0.00
Revvity (RVTY) United States $15.367B 26.91
Viatris (VTRS) United States $14.203B 4.33
CochLear (CHEOY) Australia $12.751B 0.00
Solventum (SOLV) United States $12.458B 0.00
Medpace Holdings (MEDP) United States $11.201B 33.99
Charles River Laboratories (CRL) United States $10.641B 20.11
Sonic Healthcare (SKHHY) Australia $8.811B 0.00
Doximity (DOCS) United States $7.438B 47.13
Bausch + Lomb (BLCO) Canada $7.041B 30.30
HealthEquity (HQY) United States $6.771B 36.75
PACS (PACS) United States $6.218B 0.00
Organon (OGN) United States $5.142B 5.23
Life Times (LTH) United States $4.879B 40.78
Sotera Health (SHC) United States $4.741B 23.91
Surgery Partners (SGRY) United States $4.088B 45.30
Concentras Parent (CON) United States $2.955B 0.00
GoodRx Holdings (GDRX) United States $2.789B 105.00
BrightSpring Health Services (BTSG) United States $2.550B 0.00
Ardent Health Partners (ARDT) United States $2.438B 0.00
Progyny (PGNY) United States $2.206B 38.79
Alignment Healthcare (ALHC) United States $2.177B 0.00
Premier (PINC) United States $2.052B 9.23
Ryman Healthcare (RYHTY) New Zealand $1.921B 0.00
AMN Healthcare Services Inc (AMN) United States $1.778B 8.93
Agilon Health (AGL) United States $1.642B 0.00
Teladoc Health (TDOC) United States $1.556B 0.00
CareDx (CDNA) United States $1.543B 0.00
Establishment Labs Holdings (ESTA) $1.183B 0.00
GeneDx Holdings (WGS) United States $1.044B 0.00
QDM (QDMI) Hong Kong, SAR China $0.933B 24.43
Pediatrix Medical (MD) United States $0.933B 10.15
Embecta (EMBC) United States $0.895B 5.97
InnovAge Holding (INNV) United States $0.812B 0.00
Auna S.A (AUNA) Luxembourg $0.551B 0.00
Sharecare (SHCR) United States $0.527B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.499B 0.00
Enhabit (EHAB) United States $0.410B 35.48
Sonida Senior Living (SNDA) United States $0.370B 0.00
DocGo (DCGO) United States $0.361B 13.58
Sera Prognostics (SERA) United States $0.261B 0.00
Biodesix (BDSX) United States $0.253B 0.00
LifeMD (LFMD) United States $0.226B 0.00
Ascend Wellness Holdings (AAWH) United States $0.194B 0.00
ModivCare (MODV) United States $0.192B 6.11
Beauty Health (SKIN) United States $0.187B 0.00
MultiPlan (MPLN) United States $0.152B 0.00
Nutex Health (NUTX) United States $0.126B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.083B 0.00
So-Young (SY) China $0.081B 19.72
Singular Genomics Systems (OMIC) United States $0.042B 0.00
NeueHealth (NEUE) United States $0.042B 1.66
Co-Diagnostics (CODX) United States $0.041B 0.00
OncoCyte (OCX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.030B 0.00
Pheton Holdings (PTHL) China $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.026B 0.00
Oncology Institute (TOI) United States $0.023B 0.00
SeaStar Medical Holding (ICU) United States $0.021B 0.00
TRxADE HEALTH (MEDS) United States $0.010B 0.00
XWELL (XWEL) United States $0.010B 0.00
KindlyMD (KDLY) $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00